Hematological Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.1 | Q1 | 76.7% | 1.073 | Q1 | 85.7% |
| 2024 | 3.9 | Q1 | 77.8% | 1.027 | Q1 | 84.9% |
| 2023 | 3.3 | Q2 | 60.7% | 0.820 | Q2 | 80.5% |
| 2022 | 3.3 | Q2 | 48.4% | 1.051 | Q1 | 87.3% |
| 2021 | 4.8 | Q2 | 64.7% | 0.971 | Q1 | 85.9% |
| 2020 | — | — | 0.918 | Q2 | 83.3% | |
| 2019 | — | — | 0.728 | Q2 | 77.9% | |
| 2018 | — | — | 0.650 | Q2 | 73.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0278-0232
ISSN
1099-1069
country
GBcoverage
1983-2026